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Abstract
Background: Cancer is the result of a complex multistep process that involves the accumulation of sequential
alterations of several genes, including those encoding microRNAs (miRNAs) that have critical roles in the regulation
of gene expression.
In this study, we aimed to predict potential mechanisms of bladder cancer related miRNAs and target genes by
bioinformatics analyses.
Methods: Here we used the method of text mining to identify nine miRNAs in bladder cancer and adopted
protein-protein interaction analysis to identify interaction sites between these miRNAs and related-target genes.
Results: There are two relationship types between bladder cancer and its related miRNAs: causal and unspecified.
The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment test showed that there were three pathways
related to four miRNA targeted genes. The remaining five miRNAs annotated to disease are not enriched in the
KEGG pathways. Of these, PIK3R1 is the overlapping gene among 38 genes in the cancer and bladder cancer
pathways.
Conclusions: These findings provide new insights into the role of miRNAs in the pathway of cancer and give us a
hypothesis that miR-127 might play a similar role in regulation and control of PIK3R1.
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Background
Bladder cancer is the 10th most common cancer world-
wide, with the highest rates reported in Europe, North
America and Australia compared to Eastern countries
[1,2]; there are an estimated 261,000 new cases diagnosed
and 115,000 deaths reported each year. The incidence of
bladder cancer is highly correlated with increasing age. It
rarely occurs before the age of 40 to 50 years of age, aris-
ing most commonly in the seventh decade of life [3,4].
The median ages at diagnosis are 69 years for men and 71
for women [5].
MicroRNAs (miRNAs) are a class of 17 to 27 nucleo-
tide single-stranded RNA molecules that regulate gene
expression post-transcriptionally. A large body of evi-
dence implicates aberrant miRNA expression patterns in
most, if not all, human malignancies. Indeed, cancer is
the result of a complex multistep process that involves
the accumulation of sequential alterations of several
genes and deregulation of those encoding miRNAs [6].
An increasing number of studies have demonstrated that
microRNAs can function as potential oncogenes or on-
cosuppressor genes, depending on the cellular context and
the target genes they regulate [7]. The first evidence of al-
terations of microRNA genes in human cancer came from
studies of chronic lymphocytic leukemia (CLL). In a large
study of indolent versus aggressive CLL, Calin et al. dis-
covered a signature of 13 microRNAs capable of dis-
tinguishing between indolent and aggressive CLL [8]. For
bladder cancer, Takahiro et al. demonstrated that KRT7
mRNA was significantly down-regulated by transfection of
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miR-30-3p, miR-133a and miR-199a in the bladder cancer
cell line (KK47), suggesting that these three miRNAs may
have a tumor suppressive role via the mechanism under-
lying transcriptional repression of KRT7 [9].
miRNAs and their target genes are usually validated by
quantitative real time polymer transcriptase chain reac-
tion (q-RT-PCR) and Western blot in a wet lab. How-
ever, wet lab works consumes a large amount of time
and may not be able to obtain the desired results. Hence,
we used text mining to identify nine miRNAs in bladder
cancer and adopted protein-protein interaction analysis
to identify interaction sites between these miRNAs and
target genes. We obtained a long list of statistically signifi-
cant genes without any unifying biological theme. Func-
tional annotation of differentially expressed genes is a
necessary and critical step in the analysis of microarray
data [10]. A more judicious approach offers query-based
access to an integrated database that disseminates biologic-
ally rich information across large datasets and displays
graphic summaries of functional information. Therefore,
we hope to find the important genes that are highly associ-
ated with the biological progression of bladder cancer
through the use of bioinformatics tools.
Methods
miRNAs in bladder cancer
Bladder cancer related miRNAs were drawn from
miR2Disease (http://www.mir2disease.org), which is a
manually curated database providing a comprehensive
resource of microRNA deregulation in various human
diseases [11]. The current version of miR2Disease docu-
ments 1,939 curated relationships between 299 human
microRNAs and 94 human diseases by reviewing more
than 600 published papers.
Known targets of miRNA
TarBase database houses a manually curated collection
of experimentally tested miRNA targets in human/
mouse, fruit fly, worm, and zebra fish, distinguishing
between those that tested positive and those that tested
negative [12]. A search for experimentally proven tar-
gets of nine bladder cancer-related miRNAs was
performed using the TarBase database (http://diana.
cslab.ece.ntua.gr/tarbase) (approved by the 452nd
Hospital of People’s Liberation Army).
KEGG pathway analysis
The Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway enrichment was determined by the Fisher exact
test with a P-value less than 0.05. The KEGG pathway
reveals that most target genes of miRNAs are located in
the bladder cancer pathway including the Wnt pathway
and cancer pathway. Based on this data, microRNA-
regulated gene networks associated with bladder cancer
were visualized by Cytoscape [13]. Cytoscape is an open
source bioinformatics software platform for visualizing mo-
lecular interaction networks and integrating them with
gene expression profiles and other state data. Only four
miRNAs, including oncomiR miR-21, miR-101-3p, miR-
221-3p and miR-133 were found in the miRNA-target
genes network in this study. Among the remaining five
miRNAs, miR-127 is usually differentially expressed as part
of a miRNA cluster between normal cells and cancer cells
[14]. Hence, we tried to study the functional mechanism of
miR-127 in bladder cancer.
Target genes prediction
TargetScan is a well-known software for predicting mic-
roRNA targets from conserved UTR sequences [15], in-
cluding software (miRanda) and database (microRNA.org).
Additionally, starBase is a public platform for exploring
miRNA-target interactions from CLIP-Seq (HITS-CLIP,
PAR-CLIP) and degradome sequencing (PARE) data [16]. It
also provides intersections of multiple target predictions,
such as TargetScan, PicTar, miRanda, PITA, RNA22 and
miRSVR. In this study, miRNA target genes were obtained
from TargetScan (www.targetscan.org), miRanda (www.
microrna.org), starBase (www.starbase.sysu.edu.cn) and
miRDB (www.mirdb.org), respectively (Table 1). The pos-
ition of the target site was set in the 3'UTR, with the con-
text score −0.3.
Table 1 Methods and resources for microRNA (miRNA)
target prediction
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StarBase CLIP-Seq [16] www.starbase.sysu.edu.cn
miRDB thermodynamicsa [18] www.mirdb.org
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Figure 1 MicroRNA (miRNA) to mRNA network visualized by Cytoscape. Pink dot represents target genes and red dot represents hub genes;
yellow rectangle is miRNA; blue edge indicates target gene located in the pathway of human cancer; green edge means that target gene is
located in the Wnt signaling pathway and orange edge that target gene is located in the bladder cancer pathway.
Figure 2 Illustrative screen shots from the deepView browser. The deepView browser provides an integrated view of CLIP-Seq data, known
and predicted microRNA (miRNA) target sites, protein-coding genes, non-coding (ncRNA) genes, miRNAs, strand-specific peak clusters, genome-
wide target-peaks and target-plots.
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Secondary structures of miRNA binding sites
We analyzed miRNA targets based on the common cri-
teria, including seed-pairing, free energy of miRNA: target
duplex, and proper dynamic programing score. To avoid
the incongruency brought about by different standards or
outcomes of RNA secondary structure and free energy pre-
dicted by distinct algorithms, we recalculated the secondary
structures of miRNA. Of note, microRNA-response ele-
ments (MREs) involved in duplexes and their free energy
for all predicted miRNAs were obtained from the online
database by RNAcofold, which is a program for the predic-
tion of hybrid structures of two RNA sequences (www.tbi.
univie.ac.at/ivo/RNA) [19,20]. Thus, we provided a rela-
tively equal platform or prerequisite to compare the struc-
ture of all these microRNA targets.
Results
Bladder cancer related miRNAs
There are two relationship types between bladder can-
cer and its related miRNAs: causal and unspecified.
In this study, data were filtered by selecting causal
relationships between bladder cancer and microRNA.
Of note, nine miRNAs such as hsa-miR-199a*, hsa-
miR-143, hsa-miR-127, hsa-miR-30-3p, hsa-miR-221,
hsa-miR-21, hsa-miR-101, hsa-miR-129 and hsa-miR-133a
were listed (Table 2).
Target genes of nine miRNAs and their roles in the
KEGG pathway
Target genes of nine selected miRNAs were obtained from
TargetScan and starBase databases. Then, KEGG pathway
analysis was applied to demonstrate the potential bio-
logical function of these target genes. Figure 1 shows that
target genes of four miRNAs such as hsa-miR-221, hsa-
Figure 3 Venn diagram of 38 target genes of miR-127. There are
42 genes in the bladder cancer pathway and 325 genes in the
cancer pathway.
Figure 4 Pathway in bladder cancer, without PIK3R1.
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miR-30-3p, hsa-miR-133a and hsa-miR-21 were enriched
in three pathways. The remaining five miRNAs annotated
to the disease were not enriched in the KEGG pathways.
Target prediction of miR-127
Given that miR-127 is highly embedded in a CpG island
and numerous recent studies have revealed the role of
miR-127 in human cancers [14,26], we tried to focus on
the study of target prediction of miR-127. Thirty eight tar-
get genes regulated by miR-127 were identified via five pre-
dicted software instruments including TargetScan, PicTar,
PITA, miRanda and RNA22. We also identify the binding
site of miR-127 and PIK3R1 in chromosome 5:67595672-
67595693[+] (GRCh37/hg19) via CLIP-Seq datasets in the
deepView genome browser (Figure 2).
In Figure 3, we compared the 38 predicted genes with
cancer/bladder cancer related genes and then found that
PIK3R1 is the only one gene which overlapped among
38 genes in the bladder cancer pathway (Figure 4) and
pathway of cancer (Figure 5). Therefore, we tried to de-
scribe miR-127 and its target gene PIK3R1 and their
mechanism of action in bladder cancer.
The analysis of miRNA targets was based on the com-
mon criteria, including seed-pairing, free energy of
miRNA, target duplex, and proper dynamic programing
score. To avoid the incongruency brought about by dif-
ferent standards or outcomes of RNA secondary struc-
ture and free energy predicted by distinct algorithms,
we recalculated the secondary structures of miRNA.
MicroRNA-response element (MRE) duplexes and their
free energy for all the predicted miRNAs were ob-
tained from the online database by RNAcofold. The four
most probably binding sites included SNP-56, −2236,
−2611 and −3496. Additional file 1: Table S3.
Discussion
We selected known targets of the nine miRNAs and
demonstrated their roles in biological process via KEGG
pathway analysis. The KEGG enrichment test showed
three pathways to be related to the target genes of the
four miRNAs. Only four miRNAs, including miR-21,
miR-101-3p, miR-221-3p and miR-133 were in the
miRNA-target genes network. MiR-127, one of the
remaining five miRNAs, is usually differentially expressed
as part of a miRNA cluster between normal cells and
Figure 5 Pathway in cancer, includes PIK3R1.
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cancer cells [14]. Moreover, a predicted target of miR-127,
proto-oncogene BCL6, was down-regulated after treatment
with chromatin-modifying drugs [14]. In the current study,
we focused on the study of the gene PIK3R1 which was
the only overlapping gene among 38 genes in the pathway
of cancer.
PIK3R1, also known as GRB1, p85α, p85-ALPHA, is one
of the core members involving the phosphoinositide 3-
kinase (PI3K) pathway [27]. PI3K plays a pivotal role in cell
growth, proliferation and survival and inter-signaling sys-
tems via this pathway are up-regulated in many types of
cancer [28,29]. It is strongly hypothesized that alterations
of several pathway components can affect the normal func-
tion of the PI3K pathway. Knowles et al. has identified that
alterations in pathway components PIK3CA, PTEN, AKT1
and TSC1 in bladder cancer are significantly related to
tumor phenotype and clinical behavior [30]. PIK3R1 con-
stitutively binds and inhibits the release of catalytic subunit
p110 of PI3K. Mutation of PIK3R1 has been observed in
ovarian and colon cancer [31], and higher kinase activity
was detected in breast cancer [32]. Our findings confirm
that the role of PIK3R1 can also be extrapolated in the bio-
logical process of bladder cancer.
However, no studies have investigated the role of gen-
etic variations in this pathway in bladder cancer. In this
project, we used a large case control study to evaluate
the associations of a comprehensive catalog of single nu-
cleotide polymorphisms (SNPs) in the PI3K pathway.
Four binding sites of hsa-miR-127-3p including SNP-56,
−2236, −2611 and −3496 were identified in the 3′ untrans-
lated region of PIK3R1 mRNA, suggesting that single
SNPs located at miRNA-binding sites are likely to affect
the expression of their targets and might contribute to the
pathogenesis of bladder cancer.
Conclusions
Our data demonstrate a significant association between
miR-127 and its target gene of PIK3R1 via analysis of the
CLIP-Seq data, RNA secondary structure and free energy.
The results indicate that miR-127 plays an important role
in regulating PIK3R1 that is involved in both the cancer
and bladder cancer pathways.
Additional file
Additional file 1: Table S3. Binding sits of hsa-miR-127-3p.
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